Main > A1. CORP. INDEX. M-Mm > Melinta Therapeutics Inc./P C2

---

This data is not available for free

Melinta Therapeutics Inc./P C2's subsections
2014. 02.10. Financing
2017. 06.19. ABSSSI Delafloxacin
2017. 10.30. ABSSSI Delafloxacin
2017. 11.29. Infectious Dis.
2019. 10.24. CABP Delafloxacin
2019. 12.27. Chap. 11
2020. 06.04. Acq. TetraPhase Pharma
2021. 03.15. ABSSSI>Oritavancin>USA
2021. 07.07. ABSSSI>Oritavancin>USA
2023. 07.31. USA Launch
Web-Site

Melinta Therapeutics Inc./P C2's products
This section has no products